GR3036978T3 - Anthracycline conjugates, their preparation and their use as antitumor agents. - Google Patents

Anthracycline conjugates, their preparation and their use as antitumor agents.

Info

Publication number
GR3036978T3
GR3036978T3 GR20010401848T GR20010401848T GR3036978T3 GR 3036978 T3 GR3036978 T3 GR 3036978T3 GR 20010401848 T GR20010401848 T GR 20010401848T GR 20010401848 T GR20010401848 T GR 20010401848T GR 3036978 T3 GR3036978 T3 GR 3036978T3
Authority
GR
Greece
Prior art keywords
pct
mol
image
preparation
residue
Prior art date
Application number
GR20010401848T
Other languages
English (en)
Inventor
Francesco Angelucci
Maria Grandi
Antonino Suarato
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of GR3036978T3 publication Critical patent/GR3036978T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polyamides (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR20010401848T 1993-05-11 2001-10-22 Anthracycline conjugates, their preparation and their use as antitumor agents. GR3036978T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309663A GB9309663D0 (en) 1993-05-11 1993-05-11 Biologically active compounds
PCT/EP1994/001100 WO1994026311A1 (en) 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents

Publications (1)

Publication Number Publication Date
GR3036978T3 true GR3036978T3 (en) 2002-01-31

Family

ID=10735264

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401848T GR3036978T3 (en) 1993-05-11 2001-10-22 Anthracycline conjugates, their preparation and their use as antitumor agents.

Country Status (25)

Country Link
US (1) US5571785A (el)
EP (1) EP0649312B1 (el)
JP (1) JPH08502519A (el)
KR (1) KR100330635B1 (el)
CN (1) CN1098106C (el)
AT (1) ATE203414T1 (el)
AU (1) AU671741B2 (el)
CA (1) CA2136438C (el)
DE (1) DE69427799T2 (el)
DK (1) DK0649312T3 (el)
ES (1) ES2161764T3 (el)
FI (1) FI112602B (el)
GB (1) GB9309663D0 (el)
GR (1) GR3036978T3 (el)
HU (2) HUT70509A (el)
IL (1) IL109528A (el)
MY (1) MY110974A (el)
NZ (1) NZ265266A (el)
PL (1) PL175325B1 (el)
PT (1) PT649312E (el)
RU (1) RU2145965C1 (el)
TW (1) TW268015B (el)
UA (1) UA42695C2 (el)
WO (1) WO1994026311A1 (el)
ZA (1) ZA943212B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
CA2445985A1 (en) * 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
US7049285B2 (en) * 2001-10-31 2006-05-23 Myung-Ok Park Biocompatible polymers including peptide spacer
US20050169883A1 (en) * 2002-05-06 2005-08-04 Prestwich Glenn D. Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
JP6744826B2 (ja) 2014-06-13 2020-08-19 バック バイオサイエンシーズ, エルエルシーBach BioSciences, LLC Ｆａｐ活性化治療剤及びそれに関連する使用
US9737556B2 (en) * 2014-06-13 2017-08-22 Trustees Of Tufts College FAP-activated therapeutic agents, and uses related thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
JPS60246400A (ja) * 1984-05-22 1985-12-06 Ajinomoto Co Inc アントラサイクリン系化合物及び制ガン剤
US5169937A (en) * 1986-11-18 1992-12-08 The Scripps Research Institute Method for producing stable glycosylated hemoglobin
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents

Also Published As

Publication number Publication date
EP0649312A1 (en) 1995-04-26
DE69427799T2 (de) 2002-05-02
IL109528A (en) 1998-08-16
ZA943212B (en) 1995-01-18
RU2145965C1 (ru) 2000-02-27
KR950702201A (ko) 1995-06-19
US5571785A (en) 1996-11-05
CN1098106C (zh) 2003-01-08
ES2161764T3 (es) 2001-12-16
AU6566694A (en) 1994-12-12
FI946128A0 (fi) 1994-12-28
CN1108454A (zh) 1995-09-13
PL306861A1 (en) 1995-04-18
GB9309663D0 (en) 1993-06-23
KR100330635B1 (ko) 2002-09-17
FI946128A (fi) 1994-12-28
AU671741B2 (en) 1996-09-05
FI112602B (fi) 2003-12-31
HU211538A9 (en) 1995-12-28
WO1994026311A1 (en) 1994-11-24
RU94046336A (ru) 1996-10-27
DK0649312T3 (da) 2001-11-12
DE69427799D1 (de) 2001-08-30
CA2136438A1 (en) 1994-11-24
NZ265266A (en) 1996-06-25
IL109528A0 (en) 1994-08-26
ATE203414T1 (de) 2001-08-15
UA42695C2 (uk) 2001-11-15
PL175325B1 (pl) 1998-12-31
MY110974A (en) 1999-07-31
HUT70509A (en) 1995-10-30
PT649312E (pt) 2002-01-30
EP0649312B1 (en) 2001-07-25
TW268015B (el) 1996-01-11
HU9403811D0 (en) 1995-03-28
JPH08502519A (ja) 1996-03-19
CA2136438C (en) 2004-09-14

Similar Documents

Publication Publication Date Title
DK0673258T3 (da) Polymerbundne camptothecinderivater
TW266201B (el)
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
IL113160A (en) Lipopeptide a1437 derivatives a process for their preparation and pharmaceutical compositions containing them
GR3036978T3 (en) Anthracycline conjugates, their preparation and their use as antitumor agents.
IL110830A0 (en) 9-chlor-prostaglandin derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
DK0819132T3 (da) Fremgangsmåde til fremstilling af anthracyclin-antibiotika
KR930703357A (ko) 테이코플라닌 항생물질의 38-데카르복시-38-히드록시메틸 유도체 및 그의 제조방법
HU901424D0 (en) Process for the preparation of thienyl-acetic acid derivatives and pharmaceutical compositions containing such compounds

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees